Medinex Past Earnings Performance
Past criteria checks 4/6
Medinex has been growing earnings at an average annual rate of 6.7%, while the Healthcare industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 6.4% per year. Medinex's return on equity is 10.2%, and it has net margins of 16.5%.
Key information
6.7%
Earnings growth rate
5.2%
EPS growth rate
| Healthcare Industry Growth | 9.7% |
| Revenue growth rate | 6.4% |
| Return on equity | 10.2% |
| Net Margin | 16.5% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Medinex makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 12 | 2 | 0 | 0 |
| 30 Jun 23 | 12 | 2 | 0 | 0 |
| 31 Mar 23 | 13 | 2 | 0 | 0 |
| 31 Dec 22 | 14 | 2 | 0 | 0 |
| 30 Sep 22 | 14 | 1 | 0 | 0 |
| 30 Jun 22 | 13 | 2 | 0 | 0 |
| 31 Mar 22 | 12 | 3 | 0 | 0 |
| 31 Dec 21 | 12 | 3 | 0 | 0 |
| 30 Sep 21 | 12 | 4 | 0 | 0 |
| 30 Jun 21 | 11 | 4 | 0 | 0 |
| 31 Mar 21 | 11 | 3 | 0 | 0 |
| 30 Sep 20 | 11 | 3 | 0 | 0 |
| 30 Jun 20 | 12 | 3 | 0 | 0 |
| 31 Mar 20 | 13 | 3 | 0 | 0 |
| 30 Jun 19 | 11 | 1 | 0 | 0 |
| 31 Mar 19 | 10 | 1 | 0 | 0 |
| 31 Dec 18 | 9 | 1 | 0 | 0 |
| 30 Sep 18 | 8 | 1 | 0 | 0 |
| 30 Jun 18 | 6 | 1 | 0 | 0 |
| 31 Mar 18 | 5 | 1 | 0 | 0 |
| 31 Dec 17 | 3 | 1 | 0 | 0 |
| 31 Dec 16 | 2 | 1 | 0 | 0 |
| 31 Dec 15 | 1 | 0 | 0 | 0 |
Quality Earnings: OTX has a large one-off gain of SGD628.0K impacting its last 12 months of financial results to 30th September, 2023.
Growing Profit Margin: OTX's current net profit margins (16.5%) are higher than last year (10.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OTX's earnings have grown by 6.7% per year over the past 5 years.
Accelerating Growth: OTX's earnings growth over the past year (36.7%) exceeds its 5-year average (6.7% per year).
Earnings vs Industry: OTX earnings growth over the past year (36.7%) exceeded the Healthcare industry -2%.
Return on Equity
High ROE: OTX's Return on Equity (10.2%) is considered low.